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ABSTRACT  
Cholesterol’s effects on Na+,K+-ATPase 
reconstituted in phospholipid vesicles have been 
extensively studied. However, previous studies 
have reported both cholesterol-mediated 
stimulation and inhibition of Na+,K+-ATPase 
activity. Here, using partial reaction kinetics 
determined via stopped-flow experiments, we 
studied cholesterol’s effect on Na+,K+-ATPase in 
a near-native environment in which purified 
membrane fragments were depleted of cholesterol 
with methyl-β-cyclodextrin (mβCD). The mβCD-
treated Na+,K+-ATPase had significantly reduced 
overall activity and exhibited decreased observed 
rate constants for ATP phosphorylation (ENa+3 → 
E2P, i.e. phosphorylation by ATP and Na+ 
occlusion from the cytoplasm) and K+ deocclusion 
with subsequent intracellular Na+ binding (E2K+2 
→ E1Na+3). However, cholesterol depletion did 
not affect the observed rate constant for K+ 
occlusion by phosphorylated Na+,K+-ATPase on 
the extracellular face and subsequent 
dephosphorylation (E2P → E2K+2).  Thus, partial 
reactions involving cation binding and release at 
the protein’s intracellular side were most 
dependent on cholesterol. Fluorescence 
measurements with the probe eosin indicated that 
cholesterol depletion stabilizes the 
unphosphorylated E2 state relative to E1, and 
the cholesterol depletion-induced slowing of 
ATP phosphorylation kinetics was consistent 
with partial conversion of Na+,K+-ATPase  into 
the E2 state, requiring a slow E2 → E1 transition 
before the phosphorylation. Molecular dynamics 
simulations of Na+,K+-ATPase in membranes 
with 40 mol% cholesterol revealed cholesterol 
interaction sites that differ markedly among 
protein conformations. They further disclosed 
state-dependent effects on membrane shape, 
with the E2 state being likely disfavored in 
cholesterol-rich bilayers relative to the E1P state 
because of a greater hydrophobic mismatch. In 
summary, cholesterol extraction from 
membranes significantly decreases Na+,K+-
ATPase steady-state activity.    
      
Cholesterol, present in plasma membranes of 
all animal cells, is essential for animal cell 
viability and cell development. Defects in 
enzymes of the cholesterol biosynthetic 
pathways lead to diseases such as 
desmosterolosis and Smith-Lemli-Opitz 
syndrome, which in humans are either lethal at 
an early stage of life or result in severe birth 
defects (1). Cholesterol increases packing order 
of phospholipid hydrocarbon chains, reducing 
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their freedom of motion and increasing membrane 
thickness (2). Here we concentrate on 
cholesterol’s effect on Na+,K+-ATPase activity, 
the first ion pump discovered (3). The Na+ 
electrochemical potential gradient it creates is 
used to drive nutrient reabsorption in kidney, and 
both the Na+ and K+ gradients it generates are 
essential for nerve and muscle function. 
There have been many reports of modulation 
of Na+,K+-ATPase activity by membrane 
cholesterol (4-18), but the dependence of the 
enzyme’s activity on membrane cholesterol 
composition is still not clear. For example, Lucio 
et al. (8) reported that cholesterol depletion from 
red blood cells had a biphasic effect, with a 
reduction in the cholesterol level by 5-25% 
causing Na+,K+-ATPase activation, but with a 
reduction in the cholesterol level by 35-50% 
causing inhibition, thus suggesting an optimum 
membrane cholesterol content for Na+,K+-ATPase 
function lower than the physiological level. Claret 
et al. (5) reported, also in red blood cells, that 
cholesterol depletion can cause either an increase 
or a decrease in Na+,K+-ATPase activity 
depending on the cytoplasmic Na+ concentration. 
In contrast, in vesicles extracted from kidney 
tissue Yeagle et al. (7) found that cholesterol 
depletion of the membrane only caused a decrease 
in Na+,K+-ATPase activity. The identification of 
cholesterol’s intrinsic effect on Na+,K+-ATPase 
activity in its native membrane environment and 
the elucidation of its mode of action are far from 
trivial. Much valuable information has been 
gained from studies of Na+,K+-ATPase 
reconstituted into synthetic vesicles (11, 12, 15, 
16, 19) or after detergent-solubilization (4, 17). 
The control of the enzyme surroundings such 
systems allow has enabled lipid-protein 
interactions which may be important in native cell 
membranes to be identified. Habeck et al. (17) 
carried out an analysis of membranes via mass 
spectrometry to postulate which effects may be 
operating under physiological conditions. 
However, the results of studies on reconstituted or 
detergent-solubilized protein require confirmation 
from measurements in real cell membranes. It is 
known from studies on model membrane systems 
that cholesterol’s effects vary with phospholipid 
composition. Results obtained by a variety of 
techniques indicate that cholesterol interacts more 
strongly with saturated than unsaturated 
hydrocarbon chains (2, 20-23). Thus, the 
magnitude of cholesterol’s effect on membrane 
thickness and chain order depend on phospholipid 
composition. The same applies to cholesterol’s 
effect on membrane dipole potential (23), 
suggested to modulate the kinetics of ion 
occlusion reactions of ion pumps (24). Even 
detergent molecules used to solubilize 
membrane proteins produce dipole potentials 
(25, 26) and could influence pump kinetics. To 
show that cholesterol has physiologically 
relevant effects on the Na+,K+-ATPase, 
experiments must be done on protein embedded 
in a membrane with a phospholipid composition 
closer to that of its native membrane 
environment. 
Measurements have been performed on the 
Na+,K+-ATPase in cells before and after partial 
extraction of cholesterol (5, 8, 14). However, as 
pointed out by Lucio et al. (8), a difficulty 
associated with cell studies is maintenance of 
intracellular Na+ concentration. Membrane 
cholesterol depletion is expected to increase 
membrane passive permeability to Na+ (27). 
This allows Na+ to flow into the cell, increasing 
the cytoplasmic Na+ concentration. Because 
under physiological conditions cytoplasmic 
Na+-stimulated phosphorylation by ATP is a 
major rate-determining step of the enzymatic 
cycle (28), via its effect on cytoplasmic Na+ 
level, cholesterol depletion should lead to 
Na+,K+-ATPase stimulation. But this is an 
indirect effect via a substrate level, not an 
intrinsic effect of cholesterol acting on the 
Na+,K+-ATPase from within the membrane. The 
same problem applies to any closed vesicular 
system, whether the Na+,K+-ATPase is 
reconstituted into synthetic vesicles or present in 
vesicles of the native lipid composition. It is 
difficult in any closed vesicular or cellular 
system to separate out the intramembrane effects 
of cholesterol on the Na+,K+-ATPase from its 
effects via the intracellular or intravesicular Na+ 
level. 
To avoid any effects from variation in Na+ 
membrane permeability, here we utilize open 
membrane fragments containing Na+,K+-
ATPase. The experimental procedure for their 
purification was developed by Jørgensen (29). A 
crucial step in the procedure is treatment with 
sodium dodecyl sulfate (SDS), which removes 
surface-bound proteins and disrupts closed 
microsomal preparations of the Na+,K+-ATPase, 
leading to a final preparation 90-100% pure in 
Na+,K+-ATPase with respect to protein and open 
on both sides, providing free access for both 
cytoplasmic and extracellular substrates (30, 
31). Since the development of the open 
membrane Na+,K+-ATPase system, it has been 
widely used, particularly to determine the 
kinetics of the enzyme’s partial reactions (32-
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36) and as an initial stage in protein crystallization 
(37-39). To identify the effect of cholesterol 
content on Na+,K+-ATPase activity in this system, 
cholesterol must be preferentially extracted from 
the membrane. The method by which this is 
achieved is an important consideration. Marin et 
al. (6) used cholesterol oxidase, which converts 
cholesterol to cholest-4-en-3-one. However, 
cholest-4-en-3-one is unlikely to be inert with 
respect to interaction with the Na+,K+-ATPase. 
Experiments using phospholipid vesicles show it 
causes a greater increase in dipole potential than 
cholesterol (23). Other researchers have used 
phospholipid vesicles as either cholesterol 
acceptors or carriers to perturb the binding 
equilibrium of cholesterol to Na+,K+-ATPase-
containing membranes and to either decrease or 
increase the cholesterol content (5, 7, 10). More 
recently, the use of methyl-β-cyclodextrin 
(mβCD), which forms an inclusion complex with 
cholesterol, has gained in popularity as a tool for 
manipulation of membrane cholesterol content 
(14, 23, 40, 41). The advantage of mβCD over the 
use of phospholipid vesicles is that the mβCD 
binding cavity is of an appropriate size to bind 
cholesterol preferentially over phospholipids (40). 
Therefore, it can be used to manipulate membrane 
cholesterol content while minimizing perturbation 
of the membrane’s phospholipid composition. 
Here we describe experiments in which we 
depleted open Na+,K+-ATPase-containing 
membrane fragments of cholesterol by incubation 
with mβCD. Apart from avoiding any effects from 
changes in Na+ membrane permeability, this 
system has the crucial advantage that the 
phospholipid composition of the membrane 
fragments is close to that of the native membrane. 
Analysis of the lipid composition before and after 
treatment of the initial microsomal preparation 
with SDS (42) has shown no significant change in 
the percentage of phospholipid content 
comprising sphingomyelin, phosphatidylinositol 
or phosphatidyl-ethanolamine. The 
phosphatidylserine (PS) content was found to 
increase from 7.9% to 13.1% at the expense of 
phosphatidylcholine (PC), which decreased from 
43.6% to 35.6% after SDS treatment. These 
changes could be explained by a stronger 
interaction between the Na+,K+-ATPase and the 
negatively charged PS molecule relative to the 
zwitterionic PC molecule (15, 42).Considering 
the close similarity between the lipid composition 
of the membrane fragments and the native 
membrane, changes in Na+,K+-ATPase activity 
seen on cholesterol depletion from the membrane 
fragments can be expected to reflect changes that 
would most likely be observed in the native 
environment. 
To complement the experimental studies, we 
have carried out molecular dynamics (MD) 
simulations of Na+,K+-ATPase embedded in 
membranes containing 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) and 40 mol% 
cholesterol. Most MD simulations on the 
Na+,K+-ATPase have concentrated on 
understanding the basis for Na+ or K+ selectivity 
of the protein (44-46). Here we focus on 
interaction of the protein with its surrounding 
membrane. Recently (47), simulations were 
performed in a pure DOPC membrane, i.e., in 
the absence of cholesterol. Comparison of the 
present simulations with those of Garcia et al. 
(47) has allowed us to identify changes in lipid 
packing and interaction with the Na+,K+-ATPase 
induced by cholesterol, and how these changes 
depend on the protein conformational state. The 
MD results also allow comparison with Na+,K+-
ATPase crystal structures in which cholesterol 
was found to co-crystallize (38, 48) and 
prediction of other binding sites that may 
contribute to cholesterol-dependent Na+,K+-
ATPase function. 
 
Results   
Steady-state activity  
Removal of cholesterol through incubation 
of Na+,K+-ATPase-containing membrane 
fragments with mβCD significantly reduces the 
enzyme’s steady-state activity (Fig. 1). The 
cholesterol content was measured relative to the 
protein concentration and was normalized to the 
cholesterol:protein weight ratio prior to 
cholesterol extraction, which was measured to 
be 1.1 (± 0.1) µg cholesterol/µg protein. Based 
on a molecular weight of an αβ unit of the 
Na+,K+-ATPase of 147,000 g mol-1 and the 
molecular weight of cholesterol of 387 g mol-1, 
this corresponds to a molar ratio of 
approximately 400 cholesterol molecules per 
protein unit. According to recent X-ray 
crystallographic data (16), only 13 of these 
molecules may be directly in contact with the 
protein as annular lipids, and just 3 are 
specifically bound within the protein. Thus, the 
majority of the cholesterol molecules in the 
membrane preparation are present in the bulk 
membrane phase, i.e., not in direct contact with 
the protein. The relationship between 
normalized cholesterol content (Chol/Prot) and 
the normalized ATPase activity was fitted 
arbitrarily to an exponential decay function, i.e. 
an exponential decay in the difference between 
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the normalized activity of untreated membranes 
and membranes with zero cholesterol with 
increasing Chol/Prot values. This function was 
found to provide a better fit to the experimental 
data than a hyperbolic curve. The half-maximal 
Chol/Prot value was determined to be 0.15 (± 
0.10). The cholesterol content of membrane 
fragments of enzyme prepared from pig kidney 
has been reported to be approximately 40 mol% 
of total membrane lipids (13). Thus, half-maximal 
activity of Na+,K+-ATPase is predicted from the 
data shown in Fig. 1 to occur at a membrane 
cholesterol content of ~6 mol%. 
When the enzyme is reconstituted into 
cholesterol-free phospholipid liposomes, an 
activity of ~5% of its maximal activity has been 
reported (11). Because it is very difficult or 
impossible to deplete membrane fragments totally 
of cholesterol, this value of 5% was used in the 
analysis of our experimental data as the y-
intercept. 
To test for any perturbation of the 
phospholipid content of the membranes (41), we 
measured the total phosphate content of our 
samples. After treatment of membrane fragments 
with 60 mM mβCD for 2 hrs at 37°C, the total 
phosphate content of the sample was still at 91% 
(± 8%, N = 3) relative to untreated membrane 
fragments. This agrees well with total phosphate 
measurements reported elsewhere using similar 
mβCD concentrations (49, 50), where it was found 
that treatment of plasma membranes with 40 mM 
mβCD reduced the cholesterol content to 12 – 
26% of the native level with negligible change in 
phospholipid content. 
 
Reintroduction of cholesterol  
As just described, we investigated the effect of 
mβCD on the phospholipid population of Na+,K+-
ATPase membrane fragments and observed <10% 
reduction in total phosphate. However, it has been 
postulated that mβCD binds within membrane 
interfaces and/or protein hydrophobic domains 
(51, 52). This could impact on ATPase activity. 
However, significant changes in cholesterol 
content of the membrane begin to occur before 
changes in ATPase activity are observed, 
suggesting that mβCD has a significantly higher 
affinity for cholesterol than for protein 
hydrophobic domains. If at higher mβCD 
concentrations the changes in ATPase activity 
were dominated by mβCD binding to the 
membrane interface or hydrophobic protein 
domains, then reintroduction of cholesterol via a 
cholesterol:mβCD inclusion complex should yield 
little recovery in activity. This was not the case. 
We treated cholesterol-depleted membrane 
fragments with a range of concentrations of 
cholesterol:mβCD complex and observed 
recovery in activity in all cases (Fig. 2). This 
suggests that interactions of mβCD with non-
cholesterol targets are not the dominant cause 
for the change in activity, and that it is in fact 
due to the change in cholesterol composition. 
The Na+,K+-ATPase activity of membranes 
pretreated with 30 mM mβCD could be 
completely recovered after incubation with 25 
µg of chol:mβCD complex per µg protein. 
Treatment with higher concentrations of 
chol:mβCD complex resulted in an activity drop 
below the maximum level. In comparison, the 
activity of membranes pretreated with either 45 
or 60 mM mβCD could not be completely 
recovered, although recoveries to ~75% and 
~50% of the initial untreated control activity 
were achieved. Regardless of the mβCD 
concentration used for cholesterol extraction, an 
activity increase was observed on treatment with 
low concentrations of chol:mβCD complex 
followed by a drop in activity at higher complex 
concentrations. Thus, reintroduction of too 
much cholesterol inhibits the Na+,K+-ATPase, 
and there appears to be an optimal cholesterol 
level within the membrane required to maximize 
Na+,K+-ATPase activity. This is in agreement 
with other observations (7, 53). Yeagle (53) 
suggested that inhibition at high cholesterol 
levels could be due to a specific interaction 
between cholesterol and the protein. In a later 
paper from the same group (7) it was suggested 
that it could be due to a cholesterol-induced 
increase in motional order of lipid hydrocarbon 
chains in the membrane which might decrease 
the conformational flexibility of the enzyme. 
However, regardless of the mechanism, whereas 
there is clear evidence that membrane 
cholesterol levels below the normal 
physiological level are medically relevant (e.g. 
in desmosterolosis and Smith-Lemli-Opitz 
syndrome), whether cholesterol levels above the 
normal physiological level ever occur in animals 
is unclear. It could be the case that in animal 
cells regulatory cholesterol homeostatic 
mechanisms maintain the cholesterol membrane 
composition at a constant level, so that excess 
cholesterol (e.g. from the diet) accumulates 
rather in the bloodstream, leading to 
atherosclerosis and eventually heart disease. 
      
Partial reaction kinetics  
The Na+,K+-ATPase reaction cycle consists 
of a series of partial reactions summarized by the 
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Albers-Post cycle. Here we divided the cycle into 
three steps: ENa+3 → E2P (phosphorylation by 
ATP and occlusion of Na+ from the cytoplasm), 
E2P → E2K+2 (dephosphorylation and occlusion 
of K+ from the extracellular fluid) and E2K+2 → 
E1Na+3 (K+ release to and Na+ uptake from the 
cytoplasm). To isolate reactions steps influenced 
by cholesterol removal, we carried out stopped-
flow measurements using the fluorescent probe 
RH421 (32, 34, 36, 54-57), which responds to 
local electric field strength changes associated 
with protein conformational changes. 
Experimental conditions used for isolating 
individual partial reactions are described under 
Materials and Methods. 
The effects of removal of ~90% of the 
cholesterol content of Na+,K+-ATPase membrane 
fragments on the kinetics of the ENa+3 → E2P and  
E2K+2 → E1Na+3 transitions are shown in Fig. 3. 
The observed rate constant, kobs, for the ENa+3 → 
E2P transition decreased from 138 (± 2) s-1 prior 
to cholesterol extraction to 57 (± 10) s-1 
afterwards. In the case of the E2P → E2K+2 
transition the values of kobs were 248 (± 3) s-1 and 
244 (± 24) s-1 before and after. In the case of the 
E2K+2 → E1Na+3 transition the values of kobs 
before and after cholesterol extraction were 18 (± 
1) and 4.9 (± 0.6) s-1. Thus, cholesterol removal 
causes a significant reduction in the rate constants 
of the ENa+3 → E2P and E2K+2 → E1Na+3 
transitions but has no significant effect on the rate 
constant of the E2P → E2K+2 transition. The fact 
that the kinetics of the E2P → E2K+2 transition are 
unchanged also indicates that cholesterol 
extraction has no significant effect on access of K+ 
to the enzyme’s transport site, as might be 
observed if the open membrane fragments 
underwent a transition to closed vesicles on 
cholesterol removal. 
 
RH421 fluorescence amplitudes 
A further obvious effect of cholesterol 
extraction is that it significantly decreases the 
fluorescence amplitudes of the kinetic traces. The 
fluorescence amplitude of ENa+3 → E2P partial 
reaction was reduced by 79 ± 6%, E2P → E2K+2 
by 52 ± 21% and E2K+2 → E1Na+3 by 73 ± 9%. To 
interpret this result it is important to understand 
the response mechanism of RH421. Although it is 
clear that RH421 is an electric field sensitive 
probe, the origin of the electric field strength 
changes it responds to has only recently been 
clarified (47). There it was shown that the prime 
(but not the only) cause is most likely changes in 
the degree of interaction of the protein’s highly 
charged N-terminus (containing positively 
charged lysine residues) with the membrane 
surface. Neutralisation of the dye’s negatively 
charged sulfonate group at the membrane 
surface by the lysines’ positive charge leads to 
polarisation of the dye’s electronic system and a 
wavelength shift in its visible absorbance 
spectrum. It was recently also shown (58) that 
interaction of the N-terminus with the 
membrane stabilises the protein’s E2 state and 
that release of the N-terminus from the 
membrane converts the protein into the E1 state. 
Based on this information, the reduction in the 
RH421 fluorescence amplitude changes 
observed here after cholesterol depletion could 
be interpreted as indicating that changes in the 
degree of interaction of the protein’s N-terminus 
with the membrane are significantly diminished. 
 
Eosin fluorescence measurements  
Eosin is an environmentally-sensitive 
fluorescent probe which is known to bind to the 
ATP binding site of the Na+,K+-ATPase (59, 60). 
When the protein undergoes a transition from 
the E2 to the E1 state the dye exhibits a red shift 
of its fluorescence excitation spectrum and an 
increase in its fluorescence emission intensity 
(58-60). Thus, the observed eosin fluorescence 
excitation spectrum is a sensitive indicator of 
changes in Na+,K+-ATPase conformation. 
The stopped-flow kinetic experiments on 
the ENa+3 → E2P and E2K+2 → E1Na+3 were 
carried out by initially equilibrating the enzyme 
in buffers which, based on experiments with 
native untreated enzyme, normally initially 
stabilize the E1Na+3 and E2K+2 states (see 
Experimental Procedures). However, there is no 
reason to believe that after cholesterol extraction 
the enzyme remains in the E1Na+3 or E2K+2 
state, respectively, in either of these buffers. 
Analysis of the enzyme with eosin before and 
after cholesterol treatment allowed us to 
determine if cholesterol extraction caused any 
shift in the enzyme’s conformational 
equilibrium. The eosin excitation spectra 
obtained are shown in Fig. 4. In the upper panel 
of Fig. 4 it can be seen that if the enzyme is pre-
equilibrated in a buffer containing 10 mM KCl, 
which is expected to stabilize the E2K+2 state, no 
significant change in the spectrum after 
cholesterol extraction is observed, indicating 
that the enzyme stays in the E2K+2 state. 
However, if the enzyme is pre-equilibrated in a 
buffer containing 130 mM NaCl, which is 
normally expected to stabilize the E1Na+3 state, 
a clear blue shift of the eosin spectrum and a 
significant drop in fluorescence intensity after 
                                                           Inhibition of Na+,K+-ATPase by cholesterol depletion                                                            
6 
 
cholesterol extraction are observed (see Fig. 4, 
lower panel). The spectrum observed after 
cholesterol extraction is characteristic of an E2 
state, rather than an E1 state (58-60). This result 
indicates that cholesterol extraction is causing 
some of the enzyme to shift from the E1 back into 
the E2 state, i.e. cholesterol extraction favours the 
E2 state over E1. As explained in detail in the 
Discussion, the shift towards the E2 state after 
cholesterol extraction is consistent with the 
slowing of the ENa+3 → E2P and E2K+2 → 
E1Na+3 transitions observed in the stopped-flow 
experiments. 
  
MD simulations of membrane thickness and 
cholesterol sites 
Analysis of membrane perturbations around 
the Na+,K+-ATPase in states E1P·ADP·3Na+ and 
E2·Pi·2K+ is shown in Fig. 5. Cholesterol causes 
increases in lipid bilayer thickness away from the 
protein from 29.4 ± 0.3 Å (without cholesterol 
(47)) to 34.8 ± 0.2 Å (average values based on 
simulations of both states). This is due to an 
increase in order of chains packed around 
cholesterol. Cholesterol increased order 
parameters (Fig. S4) for lipids by as much as 0.1, 
consistent with studies of pure bilayers with 40 
mol% cholesterol (61, 62). The close packing 
causes a drop in area per lipid from 59.8 ± 6.4 Å2 
without cholesterol to 45.1 ± 0.7 Å2 (Fig. S5), in 
agreement with previous membrane studies (61). 
Another consequence of the increased membrane 
thickness is the greater negative deflection 
adjacent to the protein relative to the distant 
bilayer, as seen in Fig. 5b-c (previously 2 – 3 Å 
without cholesterol (47), now as much as 6 Å), as 
the membrane responds to increased hydrophobic 
mismatch. Fig.5b reveals significant negative 
deflection in the annulus region of the protein, 
with the exception of one site of interest, with 
positive deviation near helices βM and M3 for 
both states, particularly in E1P·ADP·3Na+. This 
region (site M in Fig. 6b; to be discussed below) 
has high cholesterol density and strong 
phospholipid packing.  
Overall, the radial profile for axially-averaged 
deflections in Fig. 5c shows a defined maximum 
negative deflection at ~20 Å from the protein, 
after a small increase close to the center, arising 
from effects of the positive deflection site near 
helices βM, M3 and M7. The deflection is large in 
both states, -4.7 ± 2.2 and -6.0 ± 1.2 Å in 
E1P·ADP·3Na+ and E2·Pi·2K+, with the 
difference between the states being maintained, 
but reduced compared to previous results in 
membranes without cholesterol (-0.7 ± 1.0 and -
2.7 ± 1.3 Å for E1P·ADP·3Na+ and E2·Pi·2K+; 
(47)). Effects of cholesterol on local bilayer 
shape have the potential to modulate pump 
function. The 2-3 Å thinning of the cholesterol-
free lipid bilayer around the E2 state, relative to 
the E1 state (Fig.5c of (47)) would be associated 
with increased strain energy that should disfavor 
the E2 state. Overall this relative thinning is 
maintained (although reduced to ∼1 Å, owing to 
specific interactions with annular cholesterol 
molecules; see below). As a result of the 
stiffening of the bilayer due to cholesterol, it 
would be expected that the presence of high 
cholesterol content would increase the energetic 
cost of incorporating the more highly 
mismatched E2 state (or alternatively that 
cholesterol extraction would favor the E2 state), 
consistent with our experimental findings. 
The cholesterol density around the protein is 
shown in Fig. 6 for both states and membrane 
leaflets. Regions corresponding to density peaks 
have been classified with mean packing scores 
(Table S1), with analysis of key protein residues 
(Table S2 and Fig. S3). High scoring residues 
are mostly nonpolar, suggesting hydrophobic 
interactions and geometric factors cause 
cholesterol-protein interaction. Some sites have 
high cholesterol packing in both E1P·ADP·3Na+ 
and E2·Pi·2K+ states; in others packing is 
reduced or eliminated due to protein 
conformation changes.  
Site A in Fig. 6 represents binding in a 
crevice made by 3 helices, αM10, αM7 and βM. 
The structure 3WGU (38) for this site shows 
interaction with the same helices, and includes 
interactions identified in simulations, except for 
interaction with G52 on helix βM. Site B 
involves interactions with helices γM, αM9, 
αM10 and connecting loop L9/10. But the 
interacting residues differ markedly between 
protein states, with high scoring residues from 
αM9 in the E2·Pi·2K+ state absent in 
E1P·ADP·3Na+. This shows the hydrophobic 
interactions responsible for high cholesterol 
density are dynamic in nature. Sites A and B 
correspond to cholesterols seen in PDB 3WGU 
(E1P·ADP·3Na+) (38), but seen here in both 
E1P·ADP·3Na+ and E2·Pi·2K+ states. 
Interacting residues differ markedly between 
these states, with high scoring residues from 
αM9 absent in the E1, showing dynamic 
hydrophobic interactions. 
Site C corresponds to a crevice lined by αM2 
and αM6 helices, and the L9/10 loop. The site 
marked D in Fig. 5a is found in both 
E1·ADP·3Na+ and E2·Pi·2K+, but only with a 
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high score (0.34) in E2·Pi·2K+. Cholesterol is 
located in a gap between the αM1, αM3 and αM4 
helices. Site E is located between helices αM3 and 
αM5. However, the interacting residues differ 
between protein states, revealing a dynamic site, 
and are mostly nonpolar, with the exception of an 
interfacial serine (S303), which could interact 
with the cholesterol OH group via H-bonding. Site 
F is only found with high packing in 
E1·ADP·3Na+, with cholesterol in contact with 
helices βM and αM7, a few residues from L7/8 
and a single residue from αM5. We postulate that 
the absence of high cholesterol density in 
E2·Pi·2K+ for site F may be due to conformational 
changes involving βM movement. Site G is 
located between helices βM and αM10, forming a 
hydrophobic pocket, with some interactions with 
the interfacial K34 of the β-subunit. Site H has 
high score (0.44) in E1·ADP·3Na+ only, and is 
formed by hydrophobic interactions with αM8 and 
αM9, the connecting loop, and a residue from 
αM10. There is evidence for a low scoring site 
below H in E2·Pi·2K+ (Fig. 6), but this is further 
from the protein. Site I is formed by residues from 
γM, L8/9 and αM9. Most residues lining this site 
are hydrophobic, with an interfacial K945 of the 
α-subunit perhaps forming an H-bond with the 
cholesterol hydroxyl O. Site J has strong 
cholesterol packing in both E1·ADP·3Na+ and 
E2·Pi·2K+. Interestingly, in E2·Pi·2K+ two 
cholesterols interact, each with high scores. Site J 
is in a wide pocket between γM and αM2 helices, 
with some interactions with αM6 and αM9 helices 
in E1·ADP·3Na+, and with αM4, αM6 and αM9 
helixes and the L5/6 loop in E2·Pi·2K+. This site 
is very dynamic, with changing pose and lists of 
interacting residues, which we attribute to helical 
movements, most notably γM, which moves 
towards αM2, effectively reducing the binding 
pocket size in E1·ADP·3Na+ (likely why only one 
cholesterol molecule binds in that state). Site K 
exists in both E1·ADP·3Na+ and E2·Pi·2K+, but 
with significant packing score (0.27) only in 
E2·Pi·2K+. This site involves hydrophobic 
interactions with the αM1 helix alone. Site L is 
also only high scoring (0.28) in E2·Pi·2K+, with 
cholesterol located in a hydrophobic pocket 
formed by αM1, αM3 and αM4 helices. 
Site M is a crystallographically identified 
cholesterol site, and has high packing scores in 
E2·Pi·2K+. While no high scores are found in 
E1·ADP·3Na+ at this location, similar binding is 
seen in a region further from the protein (Fig. 6), 
with a lower packing score. This binding pocket 
resides between helices βM and αM3, and 
involves interactions that change greatly and 
includes residues from αM3, αM4, αM5, αM7 
and βM helices. All interactions are 
hydrophobic, with the exception of the 
interfacial E840 and N324 of the α-subunit, 
which interact with the cholesterol OH. Helix 
βM changes position significantly between 
E1·ADP·3Na+ and E2·Pi·2K+, with βM and 
αM3 helices moving away from αM4, αM5 and 
αM7, altering the cholesterol pocket in 
E2·Pi·2K+. Interestingly, a crystallographic 
cholesterol is observed in site M in the 3WGU 
structure (E1·ADP·3Na+) (38), though our data 
suggest more defined and stronger interaction 
should occur in E2·Pi·2K+. The crystallographic 
cholesterol suggests interactions with helices 
βM, αM5 and αM7, while no interactions with 
either αM3 or αM4 are evident. Interactions in 
the crystal structure also involve R27 on βM, 
suggesting a cholesterol site close to the 
membrane interface, while the position of 
cholesterol in our identified site varies. The 
interacting residues from αM5 are not all the 
same in the crystal structure and simulations, but 
both consist of hydrophobic residues. Site M is 
in a region where the difference in bilayer 
thickness deviation is most pronounced between 
states, with a large 7 Å positive deflection. 
Given this is the region where the N-terminus is 
likely to be located (with its conserved LKKE 
motif in the vicinity of sites K, L and M), it may 
help explain state-dependent interactions. The 
dramatic increase in membrane thickness near 
this site is associated with increased lipid 
packing (Fig. S5), that may also involve 
increased charge density driving state-
dependent interactions with the N-terminus.  
Fig.6c shows a comparison of radial free 
energy profiles, obtained from axially-
symmetrized 2D radial distribution functions for 
cholesterol around the protein center of mass in 
each bilayer leaflet. Differences in the energy of 
interaction of cholesterol between the 
E1·ADP·3Na+ and E2·Pi·2K+ states are at most 
0.1-0.2 kcal/mol, revealing a small state-
dependent binding affinity for a cholesterol 
molecule to the protein, albeit with statistically 
significant changes visible in the lipid annulus 
around the protein that favor either the 
E1·ADP·3Na+ or E2·Pi·2K+ state depending on 
the membrane side and the distance from the 
center of the protein.  Because several 
cholesterol molecules bind to the protein, the 
total energy difference between the 
E1·ADP·3Na+ and E2·Pi·2K+ states would be 
amplified. However, based on the data shown in 
Fig. 6c there is no clear systematic preference 
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for stabilisation of E1·ADP·3Na+ over E2·Pi·2K+ 
or vice versa due to protein interaction with 
cholesterol.  
Via integration of the data shown in Fig. 6c 
across both sides of the membrane to distances 
from the center of the protein which include the 
specifically bound cholesterols and annular lipids 
but exclude the bulk membrane (see Experimental 
Procedures), we have calculated that, through 
interaction with cholesterol, the free energy of the 
E1·ADP·3Na+ state of the protein is just 0.2 ± 0.2 
kcal/mol lower than that of the E2·Pi·2K+ state, 
i.e., considering the error there is no significant 
energy difference between the two states due to 
the specifically bound cholesterol molecules.  
This may suggest that cholesterol’s effect on the 
protein’s thermodynamics could instead be 
primarily via its modulation of local bilayer shape, 
rather than relative stabilization through 
preferential binding. 
 
Discussion      
     The effect of cholesterol on steady-state and 
partial reaction kinetics of Na+,K+-ATPase were 
investigated here using membrane fragments with 
a lipid composition close to that of the native 
environment. The results obtained confirm 
suggestions from previous studies using Na+,K+-
ATPase reconstituted into lipid vesicles (9, 11, 12, 
15, 16), in living cells (5, 8, 14), or after detergent-
solubilization (4, 17) that cholesterol is crucial to 
enzyme activity. Cholesterol extraction from the 
membrane fragments causes a significant drop in 
steady-state activity. 
Cholesterol removal from cell membranes or 
membrane fragments using cyclodextrin has been 
reported to have significant secondary effects on 
phospholipid content and non-specific binding to 
hydrophobic protein segments (41, 51, 52). That 
reintroduction of cholesterol through a 
cholesterol:mβCD inclusion complex was able to 
recover a significant amount of ATPase activity in 
cholesterol-depleted membrane fragments (Fig. 2) 
strongly suggests that the effects reported here are 
predominantly due to cholesterol depletion. The 
reason that incubation with the inclusion complex 
is not able to recover complete activity when the 
initial mβCD concentration used for extraction is 
≥ 45 mM is not clear at this stage, but could be due 
to the removal of a population of cholesterol 
molecules bound strongly to the protein whose 
loss may lead to protein folding changes that are 
difficult to completely reverse. The presence of 
cholesterol molecules associated directly with the 
protein has been shown by X-ray crystallography 
(38, 48) and supported by the MD simulations 
presented here. The results shown in Fig. 1 
indicate that Na+,K+-ATPase activity only drops 
sharply after the cholesterol content of the 
membrane is reduced to below 30 % of its initial 
level. This seems to indicate that removal of 
cholesterol molecules which are less strongly 
bound to the membrane have little effect on 
Na+,K+-ATPase activity.  
To isolate the cause of the drop in Na+,K+-
ATPase activity on cholesterol removal, we 
performed measurements of the enzyme’s 
partial reaction kinetics via the RH421 stopped-
flow technique. The results indicate that 
cholesterol is necessary for efficient function of 
reactions involved with intracellular 
deocclusion and release of K+ and the binding 
and occlusion of Na+. In contrast, cholesterol 
appears to play a limited role in extracellular 
binding and occlusion of K+ ions. The results 
presented from the stopped-flow data suggest an 
approximate 50 – 70% reduction in the rate 
constants of the ENa+3 → E2P and E2K+2 → 
E1Na+3 reactions on removal of ~90% of 
cholesterol in the membrane. These results are 
similar to observations of Cornelius et al. (12), 
who studied the effect of cholesterol 
composition on Na+,K+-ATPase reconstituted 
into di-18:1-PC vesicles. They found that the 
rate constants of the ENa+3 → E2P and E2K+2 → 
E1Na+3 reactions both decreased to ~50% of 
their optimum level on decreasing cholesterol 
content from 40 to 0 mol%. 
Fluorescence measurements using the 
environmentally-sensitive probe eosin indicate 
that cholesterol extraction causes a stabilisation 
of the unphosphorylated E2 state relative to 
unphosphorylated E1. This is consistent with the 
slowing of the E2K+2 → E1Na+3 transition 
observed via stopped-flow. It is also consistent 
with the observed slowing of the ENa+3 → E2P 
transition. The kinetics of this reaction depends 
critically on the enzyme’s initial conformation. 
If the enzyme is initially in the E1 state, then the 
sequence of reactions followed is E1 → E1P → 
E2P and at 24°C the observed rate constant is 
approximately 150 s-1 (63, 64), consistent with 
the results obtained here on untreated enzyme at 
the same temperature. However, if the enzyme 
is initially in the E2 state, the enzyme must first 
undergo a transition to the E1 state before 
phosphorylation by ATP can occur. Under these 
circumstances the sequence of reactions would 
be E2 → E1 → E1P → E2P. In the presence of 
ATP, previous experiments have shown that the 
E2 → E1 transition occurs with a rate constant 
of approximately 65 s-1 for pig kidney Na+,K+-
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ATPase (63). Thus, it is the rate-limiting reaction 
in the reaction sequence. The drop in the kobs for 
ATP phosphorylation from 138 (± 2) to 57 (± 10) 
s-1 after cholesterol extraction is thus consistent 
with phosphorylation starting in E2. 
The decreases in the change in RH421 
fluorescence after cholesterol extraction (see Fig. 
3) are also in agreement with a shift towards E2. 
The fluorescence intensity of RH421 associated 
with Na+,K+-ATPase-containing membrane 
fragments  is known to increase in the order E1 < 
E2 < E2P (63, 64). Thus, if cholesterol extraction 
favours the E2 state, then this should lead to a 
lower degree of conversion into the E1 state on 
mixing with NaCl and a smaller fluorescence 
drop, as experimentally observed (see Fig 3CD). 
Furthermore, because of the sequence of 
fluorescence amplitudes just given, ATP 
phosphorylation should also give a smaller 
fluorescence increase for enzyme starting in E2 
after cholesterol extraction compared to enzyme 
starting in E1, also as experimentally observed 
(see Fig. 3 AB). 
Our MD simulations have revealed state-
dependent cholesterol binding and its effects on 
local bilayer shape. While overall binding of 
cholesterol to the protein was similar between the 
states, we suggest that its primary influence could 
be on the mechanical energies to incorporate the 
different states. High cholesterol content is 
expected to raise the strain energies associated 
with increased mismatch for incorporation of the 
E2 state. This would suggest cholesterol 
extraction would favour the E2 state. However, 
the origin of the stabilization of the E2 state 
relative to E1 caused by cholesterol removal 
requires further investigation. Another possibility 
is that this stabilization could be associated with 
the protein’s lysine-rich N-terminus. A large body 
of biochemical data obtained on both the Na+,K+-
ATPase and the related H+,K+-ATPase in their 
near-native membrane environments indicates 
that the N-terminus is intimately involved in 
enzyme activity (65-71). In contrast, experimental 
data on the Na+,K+-ATPase and H+,K+-ATPase 
after exogenous expression in cell lines do not 
support a role of the N-terminus in determination 
of ion pumping activity (72, 73). A possible 
explanation for these apparently conflicting 
findings is that the effect of the N-terminus on 
ATPase activity is mediated by the membrane 
surroundings and is thus only observed when the 
protein is present in either its native membrane 
environment or one which closely approximates 
it. If this is true, then changing the lipid 
environment by cholesterol extraction could lead 
to a modulation of the effect the N-terminus has 
on pump activity. We are currently carrying out 
further studies to explore this possibility. 
In conclusion, the results obtained here 
confirm the importance of cholesterol for 
efficient function of the Na+,K+-ATPase in its 
native membrane environment. The effect of 
cholesterol depletion on Na+,K+-ATPase  
activity within the near-native membrane 
environment studied here is profound. Partial 
reactions which depend on the distribution of the 
enzyme between the unphosphorylated E1 and 
E2 states are sensitive to cholesterol depletion. 
Thus, the rate limiting partial reactions E2K+2 → 
E1Na+3 and subsequent phosphorylation by ATP 
still determine overall activity in cholesterol-
depleted membrane preparations. 
 
Experimental procedures 
Enzyme 
Na+,K+-ATPase-containing membrane 
fragments from pig kidney outer medulla were 
purified as described by Klodos et al. (74). 
Detailed lipid analyses of membrane fragments 
from mammalian kidney prepared via the same 
procedure are reported elsewhere (42, 75). The 
fragments have radii of 100 – 300 nm, as 
determined by cryoelectronmicroscopy (see Fig. 
S1). The protein concentration of the 
preparations used was 6.1 and 4.0 mg mL-1, 
determined by the Peterson (76) modification of 
the Lowry (77) method using bovine serum 
albumin as a standard. 
   
 Materials   
N-(4-Sulfobutyl)-4-(4-
(dipenylamino)phenyl)butadienyl)-pyridinium 
inner salt (RH421) was obtained from Molecular 
Probes (Eugene, OR) and was used without 
further purification. RH421 was added to 
Na+,K+-ATPase-containing membrane 
fragments from an ethanolic stock solution. 
RH421 spontaneously partitions into the 
membrane fragments. 
The origins of the other reagents used were: 
imidazole (≥99%, Sigma, Castle Hill, Australia), 
mβCD (cell-culture-tested, 1.5-2.1 methyl per 
mol glucose, Sigma), cholesterol (≥99%, 
Sigma), eosin Y (C.I. 45380, BDH, Kilsyth, 
Australia), NaCl (suprapure, Merck, Kilsyth, 
Australia), KCl (analytical grade, Merck), L-
histidine (99%, Sigma), MgCl2∙6H2O (analytical 
grade, Merck), EDTA (99%, Sigma), ATP 
disodium∙3H2O (special quality, Roche, Castle 
Hill, Australia), NADH disodium salt (approx. 
100%, grade 1, Roche), phospho(enol)pyruvic 
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acid cyclohexylammonium salt (≥97%, Sigma), 
pyruvate kinase (PK)/lactate dehydrogenase 
(LDH) from rabbit muscle (900-1400 units/ml 
LDH, 600-1,000 units/ml PK, Sigma), NaOH 
(analytical grade, Merck) and HCl (0.1 N Titrisol 
solution, Merck). 
 
Cholesterol extraction  
Cholesterol was extracted by incubating 200 
μg mL-1 of Na+-K+-ATPase-containing membrane 
fragments with mβCD (10, 20, 30, 45 or 60 mM) 
for 2 hrs at 37°C in an E1Na+3 buffer (30 mM 
imidazole, 130 mM NaCl, 5 mM MgCl2, 1 mM 
EDTA, pH 7.2),  an E2K+2 buffer (30 mM 
imidazole, 10 mM KCl, 1 mM EDTA, pH 7.4) or, 
in the case of experiments for which eosin 
fluorescence measurements were subsequently 
carried out, in a general buffer (30 mM imidazole, 
1 mM EDTA, pH 7.4). Previously published data 
from a number of laboratories (41) indicate that 
mβCD concentrations in the tens of millimolar 
range are necessary to extract cholesterol from 
both raft and non-raft domains of plasma 
membranes. Because the membrane fragments 
which we used in our experiments are derived 
from the plasma membrane and we wished to 
extract cholesterol from the entire membrane, the 
mβCD concentration range utilised here was also 
in the tens of millimolar range. To perform 
subsequent cholesterol assays and fluorescence 
experiments the enzyme was removed from 
mβCD by ultracentrifugation (75,000 g for 1 hr at 
24°C; details in the following section). The 
supernatant was then removed and the pellet 
gently resuspended in the required buffer. The 
removal of mβCD was required before any 
fluorescence measurements with RH421 or eosin 
because both probes are able to form an inclusion 
complex with mβCD which produces 
fluorescence changes unrelated to their interaction 
with the Na+,K+-ATPase. After centrifugation the 
protein concentration in the resuspended pellet 
was determined using the Peterson (76) 
modification of the Lowry (77) method. 
 
Reintroduction of cholesterol 
The cholesterol:mβCD complex was made as 
previously described (78). Briefly, a solution of 
cholesterol in methanol-chloroform (2:l v/v) was 
added in small aliquots to a stirred solution of 
mβCD (5% w/v) on a water bath (80 °C). The 
mixtures were stirred at 80 °C until complete 
dissolution of the initially precipitating steroid. 
Quantities of substrates were 30 mg of cholesterol 
to 1 g of mβCD. The solutions were freeze-dried 
and stored at -20 °C. 
Reintroduction of cholesterol to the 
membrane fragments was performed after 
ultracentrifugation, described above. A stock 
concentration of the cholesterol:mβCD 
inclusion complex was dissolved in E1Na+3 
buffer. Concentrations varied from 5 µg of 
inclusion complex per µg protein to 400 µg of 
inclusion complex per µg protein. Membrane 
fragments with the inclusion complex and the 
control sample were incubated for 2 hrs at 37 °C 
prior to measurement of ATPase activity. 
       
Cholesterol assay  
Cholesterol levels of Na+,K+-ATPase-
containing membrane fragments were 
determined before and after treatment with 
mβCD via the Amplex Red cholesterol assay kit 
(Molecular Probes, Eugene, OR). Membrane 
fragments treated with mβCD were first 
separated from mβCD via ultracentrifugation 
(75,000 g for 1 hr at 24ºC) using an Optima XE-
100 ultracentrifuge and SW 32 Ti Swinging-
Bucket Rotor (Beckman Coulter, Lane Cove, 
Australia) to prevent contamination from 
cholesterol present in the aqueous solution, e.g. 
complexed with mβCD. Cholesterol standards 
(0.25 to 16 µg/ml) and membrane fragments (75 
µl) were pipetted into microfuge tubes and 
incubated with reagent (300 μM Amplex Red, 2 
units/ml horse radish peroxidase, 2 units/ml 
cholesterol oxidase, 0.2 units/ml cholesterol 
esterase) at 37ºC for 30 min in the dark. 
Fluorescence intensity measurements were then 
performed in duplicate with an RF-5301 PC 
spectrofluorophotometer (Shimadzu, Kyoto, 
Japan) using 1 cm pathlength quartz 
microcuvettes. Temperature was maintained at 
37ºC via a circulating water bath. The values of 
λex and λem were 545 nm and 590 nm (bandwidth 
5 nm) with an OG570 filter (Schott, Mainz, 
Germany) in front of the photomultiplier. 
 
Steady-state activity measurements 
The specific ATPase activity of Na+,K+-
ATPase was determined by the PK/LDH 
coupled assay at 37ºC (79) in buffer containing 
25 mM imidazole, 100 mM NaCl, 10 mM KCl, 
5 mM MgCl2, 3 mM Na2ATP, 2 mM 
phospho(enol)pyruvate and an approximate 
final concentration of 5 U/ml of PK and 7 U/ml 
of LDH. Buffer pH was adjusted to 7.2 with 
HCl. At the beginning of each experiment, i.e. 
prior to initiating the reaction by adding Na+,K+-
ATPase-containing membrane fragments, 80 
μM of NADH was added directly to the solution 
in a 1 cm pathlength cuvette. The time course of 
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the drop in NADH absorbance caused by ATPase 
activity was monitored at 340 nm using a UV-
2450 UV-visible spectrophotometer (Shimadzu, 
Kyoto, Japan). At least 99% of the activity could 
be blocked by addition of 1 μM ouabain, a specific 
Na+,K+-ATPase inhibitor. 
 
Estimation of phospholipids  
Lipid phosphate was assayed after total 
digestion by nitric acid-calcium carbonate 
solution with Na2HPO4 as a standard using the 
method of Baginski et al. (80). Samples treated 
without nitric acid-calcium carbonate solution 
produced negligible absorbance changes. 
 
Stopped-flow fluorimetry 
Stopped-flow experiments were performed 
using an SF-61SX2 stopped-flow 
spectrofluorimeter (TgK Scientific, Bradford on 
Avon, UK) as described previously (32, 54, 81). 
All solutions were equilibrated to a temperature 
of 24°C before measuring the kinetics. The 
methods used to study different enzyme partial 
reaction kinetics are explained briefly below. 
For the ENa+3 → E2P reaction, Na+,K+-
ATPase-containing membrane fragments (10 
μg/ml of enzyme), labelled with RH421 (250 
nM), were pre-mixed in one drive syringe with 
130 mM NaCl to stabilize the ENa+3 state. The 
enzyme was then mixed with an equal volume of 
2 mM Na2ATP solution from the other drive 
syringe. Both enzyme suspension and ATP 
solution were prepared in the same buffer (30 mM 
imidazole, 130 mM NaCl, 5 mM MgCl2, 1 mM 
EDTA). The Mg2+ ions allow ATP to 
phosphorylate the protein after the solutions are 
mixed (81). Buffer pH was adjusted to 7.2 with 
HCl. 
The kinetics of the E2P → E2K+2 transition 
were determined by first adding 1 mM of Na2ATP 
to a suspension of Na+,K+-ATPase-containing 
membrane fragments (30 μg/ml of enzyme), 
labelled with 250 nM RH421, in one of the 
stopped-flow drive syringes. The enzyme 
suspension was in buffer containing 30 mM 
imidazole, 130 mM NaCl, 5 mM MgCl2 and 1 
mM EDTA (as in ENa+3 → E2P experiments). 
Thus, the enzyme is already phosphorylated by 
ATP in the drive syringe. The enzyme suspension 
was then mixed with an equal volume of 20 mM 
KCl solution. The KCl solution was prepared in 
the same buffer as the enzyme suspension and 
also contained 1 mM Na2ATP. Buffer pH was 
adjusted to 7.2 with HCl. 
To determine the kinetics of the E2K+2 → 
E1Na+3 transition, Na+,K+-ATPase-containing 
membrane fragments (30 μg/ml of enzyme), 
labelled with RH421 (250 nM) were pre-mixed 
in one of the drive syringes with 10 mM KCl to 
stabilize the E2K+2 state. The enzyme was then 
mixed with an equal volume of solution 
containing 260 mM NaCl and 2 mM Na2ATP 
from the other drive syringe. To avoid any 
changes in K+ concentration on mixing, 
solutions in both drive syringes were prepared 
in 30 mM histidine, 10 mM KCl and 1 mM 
EDTA. The pH was adjusted to 7.2 with HCl. 
The absence of Mg2+ ions prevents 
phosphorylation by ATP, but still allows ATP 
to act in an allosteric fashion, accelerating the 
E2K+2 → E1Na+3 transition. 
To improve the signal/noise ratio, typically 
between 9 and 21 experimental traces were 
averaged before observed rate constants, kobs, 
and relative fluorescence changes, ΔF/F0, were 
evaluated. This was done by fitting a sum of 
either 1 or 2 exponential functions to the 
averaged trace. The choice between a single- or 
double-exponential fit was based on residual 
plots and values of the Χ2 parameter. 
 
Eosin fluorescence measurements 
All fluorescence measurements using eosin 
were carried out using an RF-5301 PC 
spectrofluorophotometer (Shimadzu, Kyoto, 
Japan) with 1 cm pathlength quartz semi-
microcuvettes. 100 μL of either E1-stabilizing 
buffer (30 mM imidazole, 130 mM NaCl, 5 mM 
MgCl2, 1 mM EDTA, pH 7.2) or E2-stabilizing 
buffer (30 mM imidazole, 10 mM KCl and 1 
mM EDTA, pH 7.2), 7.4 μL of Na+,K+-ATPase-
containing membrane fragments (3.2 mg mL-1 
in 30 mM imidazole, 1 mM EDTA, pH 7.2) and 
2.9 μL of eosin (1.1 μM in water) were 
consecutively added to the cuvette. The 
temperature was maintained at 24ºC via a 
circulating water bath. The value of emission 
wavelength used was 550 nm (bandwidth 5 nm) 
with an OG530 cut-off filter (Schott, Mainz, 
Germany) in front of the photomultiplier. 
The final Na+,K+-ATPase concentration in 
the cuvette was 230 μg/ml. This concentration 
was chosen based on previous studies by Skou 
and Esmann (59, 60) in order to saturate the 
eosin with protein and ensure that all of the 
measured fluorescence derives from protein-
bound eosin and any fluorescence from eosin in 
the neighboring aqueous solution can be 
neglected. In the case of membranes from which 
cholesterol had been extracted using mβCD, the 
percentage of cholesterol extracted after 
treatment was determined to be 99.8% based on 
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cholesterol assays before and after mβCD 
treatment. 
 
Statistical analysis 
Statistical analysis was performed in 
Graphpad Prism 7. Comparisons were performed 
using an unpaired t-test with statistical 
significance defined as P < 0.05. 
 
MD simulations 
Available structures of pig Na+,K+-ATPase in 
E1 and E2 states (PDB codes 3WGU (38) and 
3B8E (39) were embedded in bilayers of DOPC 
(264 and 261 lipids, respectively) and 40 mol%  
cholesterol (176 and 178 molecules, respectively) 
immersed in 150 mM NaCl solution using explicit 
TIP3P water molecules, with the E1 system 
containing 267,757 atoms and E2 containing 
226,973 atoms. Four copies of each system were 
built with random distributions of cholesterol 
using CHARMM-GUI (82), and equilibrated 
using NAMD 2.9 (83) with the CHARMM36 
force field (84, 85). Temperature was maintained 
at 303.15 K via a Langevin thermostat, with the 
pressure set at 1 atm with the Nose-Hoover 
Langevin piston method (86) using rectangular 
periodic boundary conditions. The temperature 
was chosen to match standard conditions in 
previous experimental studies of pure DOPC 
bilayers (87). A further increase in temperature by 
7°C to body temperature is expected to cause only 
a minimal change in membrane hydrophobic 
thickness of 0.35 Å (88). Similar systems without 
cholesterol (47) were used as reference. The lipid 
composition of DOPC and 40 mol% cholesterol 
was chosen based on experimental reconstitution 
studies indicating that this composition allows the 
enzyme to regain full activity (11). 
For 2-D maps of carbonyl C to C membrane 
deflection, the lipid bilayer thickness was 
computed on a 2 × 2 Å xy grid, offset by removing 
the average away from the protein to obtain a 
measure of deflection. Error bars are the standard 
error of means obtained from the 4 independent 
runs. All other simulation procedures were as 
described previously (47). Perturbations far from 
the protein in Fig.5b are due to the influence of the 
protein from the neighboring periodic image.  
Cholesterol density was computed on a 2 × 2 
Å xy grid for each membrane leaflet separately. 
All values were computed relative to the average 
density away from protein, yielding maps of 
relative cholesterol density. A reproducibility 
test was performed by analysing all simulations 
independently in Fig. S2. Areas near the protein 
that exhibited peaks in density were visually 
inspected in VMD to identify residues that might 
facilitate favourable interactions with 
cholesterol (Fig. S3). The cholesterol density, 
relative to far from the protein, ρ(x, y), has been 
converted to a 2-D axially-averaged radial 
distribution function, g(r), normalized to 
converge to 1 far from the protein, from which 
we have calculated a radial free energy profile 
𝛥𝛥𝛥𝛥(𝑟𝑟)  =  −𝑘𝑘𝐵𝐵𝑇𝑇 ln𝑔𝑔(𝑟𝑟), where kB is 
Boltzmann’s constant, and T is the absolute 
temperature. We offset 𝛥𝛥𝛥𝛥(𝑟𝑟) so that it is 0 in 
the bulk (𝛥𝛥𝛥𝛥𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏= 0), defined by the average in 
the region between 50 and 60 Å from the protein 
center-of-mass. We have calculated the net 𝛥𝛥𝛥𝛥 
for the relative binding of a cholesterol molecule 
to the E2 relative to the E1P state, including both 
leaflets of the membrane, as 
𝛥𝛥𝛥𝛥𝐸𝐸1→𝐸𝐸2 = −𝑘𝑘𝐵𝐵𝑇𝑇 ln 𝐾𝐾𝐷𝐷𝐸𝐸2−1𝐾𝐾𝐷𝐷𝐸𝐸1−1 = −𝑘𝑘𝐵𝐵𝑇𝑇 ln 𝐾𝐾𝐷𝐷𝐸𝐸1𝐾𝐾𝐷𝐷𝐸𝐸2, 
where 𝐾𝐾𝐷𝐷𝐸𝐸1  and 𝐾𝐾𝐷𝐷𝐸𝐸2are dissociation constants, 
computed for states E1P and E2, respectively, as 
𝐾𝐾𝐷𝐷
−1 = ∫ 𝑒𝑒−𝛥𝛥𝛥𝛥(𝑟𝑟)/𝑘𝑘𝐵𝐵𝑇𝑇
𝑒𝑒−𝛥𝛥𝛥𝛥𝑏𝑏𝑏𝑏𝑏𝑏𝑘𝑘/𝑘𝑘𝐵𝐵𝑇𝑇 𝑟𝑟𝑟𝑟𝑟𝑟𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 , where “bound” 
is defined as the region between r = 0 and 30 Å 
from the protein center-of-mass, corresponding 
to the lipid annulus with defined cholesterol 
binding sites in Fig.6b and c.  
Packing scores for cholesterols around the 
protein were computed as the sum of all 1/r6 
terms for all atoms of a cholesterol molecule that 
exist within 5 Å of any atom of the protein, 
averaged over the simulations (88). Sites with at 
least one binding pose with a total packing score 
> 0.25 were considered high scoring (Table S1) 
and visualised in Fig. S3. Contributions from 
specific residues of the protein were computed 
as the sum of all 1/r6 terms between any atom of 
a cholesterol molecule and any atom of a 
specific protein residue within 5 Å. 
Contributions from any residue were considered 
high and reported in Table S2 and in Fig. S3, if 
> 0.02. 
Lipid chain order parameters as a function of 
carbon number for lipid tails, were computed 
using SCD = <(3cos2α – 1)/2>, where α is the 
angle of each C-H vector to the bilayer normal. 
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Figure 1. Dependence of relative Na+,K+-ATPase (NKA) activity on normalized relative membrane 
cholesterol content. Cholesterol extraction was performed using sequentially higher concentrations of 
mβCD, and ATPase activity was measured after mβCD removal. (Solid line) Nonlinear least-squares 
fit of an exponential decay curve to the data, i.e., the fit function was y = y0 + (ymax – y0)∙(1- e-kx). k is 
here the reciprocal of the relative membrane cholesterol content at which the difference between the 
normalized Na+,K+-ATPase activity and its value at zero cholesterol content has dropped to 1/e of its 
initial value at zero cholesterol content. The half-saturating relative membrane cholesterol content was 
determined to be 0.15 (±0.10). The Na+,K+-ATPase activity of untreated membranes was 1671 (± 71) 
μmol ATP hydrolyzed (mg protein)-1 hr-1 (N = 7). 
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Figure 2. Effect of reintroduction of cholesterol through a cholesterol:mβCD complex to membrane 
fragments treated with different concentrations of mβCD (30, 45 and 60 mM). Measurements are given 
as relative activity to untreated controls and are an average of 3 measurements with the errors presented 
as standard deviations. 
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Figure 3. Stopped-flow fluorescence transients of Na+,K+-ATPase from pig kidney noncovalently 
labeled with RH421. Panels A and B show the kinetics of the E1Na+3 → E2P transition of an untreated 
control (panel A) and membrane fragments treated with 60 mM mβCD (panel B). Panels C and D show 
the kinetics of the E2K+2 → E1Na+3 transition of an untreated control (panel C) and membrane 
fragments treated with 60 mM mβCD (panel D). All experimental conditions are described under 
Experimental Procedures. 
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Figure 4. Fluorescence excitation spectra of eosin.  The fluorescence intensity is given in arbitrary 
units. The upper panel represents eosin in the presence of Na+,K+-ATPase membrane fragments from 
which cholesterol was either extracted (solid line) or an untreated control (dotted line) in E2K+2 buffer 
(30 mM imidazole, 10 mM KCl, 1 mM EDTA, pH 7.2).The lower panel represents eosin in the presence 
of Na+ K+-ATPase membrane fragments from which cholesterol was either extracted with mβCD  (solid 
line) or an untreated control (dotted line) in E1Na+3 buffer (30 mM imidazole, 130 mM NaCl, 5 mM 
MgCl2, 1 mM EDTA, pH 7.2). The emission wavelength was 550 nm (+OG530 cutoff filter). The 
bandwidths for both excitation and emission were 5 nm. The eosin and Na+,K+-ATPase concentrations 
were 29 nM and 230 μg mL-1 in every case. Cholesterol extraction was achieved by equilibrating the 
Na+,K+-ATPase membrane fragments with 60 mM mβCD for 2 hours at 37 °C. The spectra were 
recorded at a temperature of 24 °C. 
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Figure 5.  (a) Na+,K+-ATPase simulation systems: E1P·ADP·3Na+ (left, “E1”, PDB 3WGU) and 
E2·Pi·2K+ (right, “E2”, PDB 3B8E). (b) Bilayer thickness deviation is based on glycerol C to glycerol 
C distance between lipids in each leaflet, viewed from the cytoplasm. Deviation is relative to thickness 
far from the protein, with an average of 34.8 ± 0.2 Å for both states. (c) Axially-averaged bilayer 
thickness, defined as the glycerol-carbon-to-glycerol-carbon distance between lipids in each membrane 
leaflet. The error bars represent ± one standard error of means. 
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Figure 6. Cholesterol density for each membrane leaflet relative to the mean far from the protein. The 
left column shows the distribution for E1P·ADP·3Na+ (PDB 3WGU, “E1”) and the right column 
E2·Pi·2K+ (PDB 3B8E, “E2”). Density is viewed from the cytoplasm. Reproducibility of the 4 
simulations for each state is shown in Fig. S1. Sites with a cholesterol packing score of ≥ 0.25 for at 
 least one state are indicated with letters A – M, with green letters for sites unique to one state (packing 
scores in Table S1). a) Shows results for extracellular side, while b) shows results for cytoplasmic site. 
c) Radial free energy profile for cholesterol binding, shown in blue for extracellular leaflet and red for 
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cytoplasmic leaflet. Darker colours represent the E1 state, while lighter ones represent the E2 state, as 
labelled. 
